Binh Dinh Pharmaceutical and Medical Equipment Share Price

Equities

DBD

VN000000DBD0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 03:30:00 09/05/2024 am IST 5-day change 1st Jan Change
52,900 VND -0.19% Intraday chart for Binh Dinh Pharmaceutical and Medical Equipment -0.56% -2.40%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 1,844B 71.92M 6.05B Sales 2025 * - Capitalization 3,959B 154M 12.98B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 2.15 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 1,303
Yield 2024 *
3.78%
Yield 2025 *
-
Free-Float 73.8%
More Fundamentals * Assessed data
Dynamic Chart
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces Appointment of Pham Thi Thanh Huong as CEO CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces Appointment of Huynh Ngoc Oanh as Deputy CEO CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Approves Dividend for the Year 2022 and Provides Dividend Guidance for the Year 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Approves Earnings Guidance for the Year 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Approves to Implement the Investment Plan to Build the Production Factory CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces the Change in Personnel, Effective from April 21, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces Board Changes CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Approves Cash Dividend, Payable April 10, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
More news
1 day-0.19%
1 week-0.56%
Current month-0.56%
1 month-4.34%
3 months-2.40%
6 months-9.57%
Current year-2.40%
More quotes
1 week
52 500.00
Extreme 52500
53 100.00
1 month
52 200.00
Extreme 52200
54 800.00
Current year
52 200.00
Extreme 52200
57 400.00
1 year
43 000.00
Extreme 43000
60 000.00
3 years
30 489.51
Extreme 30489.5105
60 000.00
5 years
28 706.29
Extreme 28706.2937
60 000.00
10 years
24 475.52
Extreme 24475.5245
60 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 01/10/01
Chairman 63 01/83/01
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 45 17/21/17
Chairman 63 01/83/01
Chief Executive Officer 58 01/10/01
More insiders
Date Price Change Volume
09/24/09 52,900 -0.19% 103 900
08/24/08 53,000 +0.57% 33,600
07/24/07 52,700 -0.57% 69,100
06/24/06 53,000 -0.19% 77,000
03/24/03 53,100 0.00% 75,700

End-of-day quote Ho Chi Minh S.E., May 09, 2024

More quotes
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities are the production and wholesale of medicines, including antibiotics, antipyretics, pain relievers, cardiovascular drugs, antifungal and antiviral drugs, respiratory drugs, vitamins and functional food, among others. Bidiphar is also involved in the manufacture and distribution of medical equipment, supplies and packaging.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
53,000 VND
Average target price
58,000 VND
Spread / Average Target
+9.43%
Consensus

Chiffre d''affaires - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW